CONMED Corp — Director's Dealing 2021

Jan 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2021-01-19

Reporting Person: Cohen Heather L (EVP CORP HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-19	Common Stock	M	5000	$27.63	Acquired	26798	Direct
2021-01-19	Common Stock	F	2533	$116.98	Disposed	24265	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-19	Sars (Stock Appreciation Rights)	$27.63	M	5000	Disposed	2021-06-01	Common Stock (5000)	Direct

Footnotes

F1: The exercise reported above was pursuant to a previously adopted 10b5-1 Plan.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.